China, South Korea, and India driving innovation in medical robotics in APAC: GlobalData

China, South Korea, and India driving innovation in medical robotics in APAC: GlobalData

GlobalData, a data and analytics company, on Monday, said that increased focus on medical robotic development across Asia-Pacific (APAC) will fuel innovation in the region over

GlobalData, a data and analytics company, on Monday, said that increased focus on medical robotic development across Asia-Pacific (APAC) will fuel innovation in the region over

the next five years. According to the data and analytics company, this trend will mainly be driven by China, South Korea, and India. GlobalData’s latest

the next five years. According to the data and analytics company, this trend will mainly be driven by China, South Korea, and India. GlobalData’s latest

report, ‘Robotics in Healthcare’, reveals that APAC has the highest patenting activity for robotics in healthcare globally. Indeed, China leads the world with over 2,800 patent

report, ‘Robotics in Healthcare’, reveals that APAC has the highest patenting activity for robotics in healthcare globally. Indeed, China leads the world with over 2,800 patent

applications between January 2016 and December 2022. Nearly 9,000 applications were filed globally during that period, with around 2,600 coming from the US, over 560 from Japan,

applications between January 2016 and December 2022. Nearly 9,000 applications were filed globally during that period, with around 2,600 coming from the US, over 560 from Japan,

and South Korea filing more than 370. “The APAC region is the third largest market for surgical robotics behind North America and Europe. Increasing healthcare

and South Korea filing more than 370. “The APAC region is the third largest market for surgical robotics behind North America and Europe. Increasing healthcare

expenditure markets such as India and China are driving the demand for robotic surgical procedures, as are other government policies. However, high device prices and lack of

expenditure markets such as India and China are driving the demand for robotic surgical procedures, as are other government policies. However, high device prices and lack of

healthcare facilities continue to hinder market growth, particularly in developing countries in the region,” Jemima Walker, Thematic Intelligence Analyst at GlobalData, said in a

healthcare facilities continue to hinder market growth, particularly in developing countries in the region,” Jemima Walker, Thematic Intelligence Analyst at GlobalData, said in a

statement. Also ReadGlobal cardiomyopathies market set to reach $9.63 billion by 2031 driven by US and China’s drug sales: GlobalData APAC to see a reduction in imported

statement. Also ReadGlobal cardiomyopathies market set to reach $9.63 billion by 2031 driven by US and China’s drug sales: GlobalData APAC to see a reduction in imported

surgical robotics Rapid urbanisation and population growth across APAC will increase the number of patients requiring surgical intervention. Healthcare providers will

surgical robotics Rapid urbanisation and population growth across APAC will increase the number of patients requiring surgical intervention. Healthcare providers will

increasingly invest in surgical robots to meet patient needs.

increasingly invest in surgical robots to meet patient needs.